Protagenic Therapeutics, Inc.
PTIX
$0.49
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 189.09% | 148.40% | 169.01% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 130.47% | 213.42% | 275.51% | ||
| Operating Income | -130.47% | -213.42% | -275.51% | ||
| Income Before Tax | 360.00% | -48.66% | -1,471.63% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 360.00% | -49.30% | -1,459.03% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 360.00% | -49.30% | -1,459.03% | ||
| EBIT | -130.47% | -213.42% | -275.51% | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 825.00% | -335.77% | -2,173.54% | ||
| Normalized Basic EPS | 824.97% | -333.33% | -2,189.54% | ||
| EPS Diluted | 825.00% | -335.77% | -2,173.54% | ||
| Normalized Diluted EPS | 824.97% | -333.33% | -2,189.54% | ||
| Average Basic Shares Outstanding | -64.14% | -65.72% | -31.40% | ||
| Average Diluted Shares Outstanding | -64.14% | -65.72% | -31.40% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||